AGP Picks
View all

Florida Tech Today
Provided by AGP

Florida Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on August 10, 2026

Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
Aug. 10, 2026

Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval

Indeterminate GlobeNewswire
STACK Infrastructure Proudly Supports Governor Abbott in Advancing Responsible Data Center Growth in Texas
Aug. 10, 2026

STACK Infrastructure Proudly Supports Governor Abbott in Advancing Responsible Data Center Growth in Texas

Indeterminate GlobeNewswire
Replimune Announces Pricing of $150 Million Underwritten Offering
Aug. 10, 2026

Replimune Announces Pricing of $150 Million Underwritten Offering

Indeterminate GlobeNewswire
Initta Technology Showcases AI-Powered Retail Solutions at Nanchang Partner Conference
Aug. 10, 2026

Initta Technology Showcases AI-Powered Retail Solutions at Nanchang Partner Conference

Indeterminate GlobeNewswire
Quantum Cyber Files Lawsuit Against White Diamond Research, Adam Gefvert and Stocktwits, Inc. in New York Supreme Court
Aug. 10, 2026

Quantum Cyber Files Lawsuit Against White Diamond Research, Adam Gefvert and Stocktwits, Inc. in New York Supreme Court

Indeterminate GlobeNewswire
One Movie Lover Unlocked More Than $17,000 in CineClub Member Benefits in Five Years as Canadians Look for More Affordable Ways to Go Out
Aug. 10, 2026

One Movie Lover Unlocked More Than $17,000 in CineClub Member Benefits in Five Years as Canadians Look for More Affordable Ways to Go Out

Indeterminate GlobeNewswire
Dans un contexte où les Canadiens rêvent de sorties plus abordables, un cinéphile a profité de plus de 17 000 $ d’avantages CinéClub en cinq ans
Aug. 10, 2026

Dans un contexte où les Canadiens rêvent de sorties plus abordables, un cinéphile a profité de plus de 17 000 $ d’avantages CinéClub en cinq ans

Indeterminate GlobeNewswire
CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Aug. 10, 2026

CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire
Eikon Therapeutics Appoints Johnny Bennett, Ph.D. to its Scientific Advisory Board
Aug. 10, 2026

Eikon Therapeutics Appoints Johnny Bennett, Ph.D. to its Scientific Advisory Board

Indeterminate GlobeNewswire
3D Systems Receives $9 Million Contract Award from U.S. Air Force for Advanced Large-Format Metal 3D Printing System
Aug. 10, 2026

3D Systems Receives $9 Million Contract Award from U.S. Air Force for Advanced Large-Format Metal 3D Printing System

Indeterminate GlobeNewswire
SAIC Appoints Financial Services Leader David Benson and Business Transformation Expert David Cush to Board of Directors
Aug. 10, 2026

SAIC Appoints Financial Services Leader David Benson and Business Transformation Expert David Cush to Board of Directors

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories CEO Kim Thompson Publishes Thought Leadership Article on the Next Chapter of Authored Biology in Biocompare
Aug. 10, 2026

Kraig Biocraft Laboratories CEO Kim Thompson Publishes Thought Leadership Article on the Next Chapter of Authored Biology in Biocompare

Indeterminate GlobeNewswire
Notice of Extraordinary General Meeting of Shareholders of Kaspi.kz
Aug. 10, 2026

Notice of Extraordinary General Meeting of Shareholders of Kaspi.kz

Indeterminate GlobeNewswire
Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 10, 2026

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results
Aug. 10, 2026

MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates
Aug. 10, 2026

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

Indeterminate GlobeNewswire
Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 10, 2026

Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film
Aug. 10, 2026

Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film

Indeterminate GlobeNewswire
Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights
Aug. 10, 2026

Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire
BrewDog Claims London's Summer Park Season with ‘Park IPA’
Aug. 10, 2026

BrewDog Claims London's Summer Park Season with ‘Park IPA’

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Florida Tech Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.